Colorado Secures Legal Win as Federal Judge Dismisses Amgen’s Drug Price Cap Challenge

A Colorado federal judge recently dismissed Amgen’s legal challenge against the state’s drug price cap legislation. The court determined that Amgen, a leading biopharmaceutical company, does not face “direct regulation” under the current law, rendering the company without standing to file the lawsuit. As a result, the price cap system remains intact, providing the state with a temporary victory in its ongoing efforts to control drug costs. For further details on the case, visit the full article on Law360.